SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
- PMID: 32668444
- DOI: 10.1038/s41586-020-2550-z
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Abstract
Memory T cells induced by previous pathogens can shape susceptibility to, and the clinical severity of, subsequent infections1. Little is known about the presence in humans of pre-existing memory T cells that have the potential to recognize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we studied T cell responses against the structural (nucleocapsid (N) protein) and non-structural (NSP7 and NSP13 of ORF1) regions of SARS-CoV-2 in individuals convalescing from coronavirus disease 2019 (COVID-19) (n = 36). In all of these individuals, we found CD4 and CD8 T cells that recognized multiple regions of the N protein. Next, we showed that patients (n = 23) who recovered from SARS (the disease associated with SARS-CoV infection) possess long-lasting memory T cells that are reactive to the N protein of SARS-CoV 17 years after the outbreak of SARS in 2003; these T cells displayed robust cross-reactivity to the N protein of SARS-CoV-2. We also detected SARS-CoV-2-specific T cells in individuals with no history of SARS, COVID-19 or contact with individuals who had SARS and/or COVID-19 (n = 37). SARS-CoV-2-specific T cells in uninfected donors exhibited a different pattern of immunodominance, and frequently targeted NSP7 and NSP13 as well as the N protein. Epitope characterization of NSP7-specific T cells showed the recognition of protein fragments that are conserved among animal betacoronaviruses but have low homology to 'common cold' human-associated coronaviruses. Thus, infection with betacoronaviruses induces multi-specific and long-lasting T cell immunity against the structural N protein. Understanding how pre-existing N- and ORF1-specific T cells that are present in the general population affect the susceptibility to and pathogenesis of SARS-CoV-2 infection is important for the management of the current COVID-19 pandemic.
Similar articles
-
Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.J Immunol. 2020 Nov 1;205(9):2437-2446. doi: 10.4049/jimmunol.2000717. Epub 2020 Sep 2. J Immunol. 2020. PMID: 32878912 Free PMC article.
-
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19.Nature. 2020 Nov;587(7833):270-274. doi: 10.1038/s41586-020-2598-9. Epub 2020 Jul 29. Nature. 2020. PMID: 32726801
-
Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.Immunity. 2020 Nov 17;53(5):1095-1107.e3. doi: 10.1016/j.immuni.2020.10.006. Epub 2020 Oct 20. Immunity. 2020. PMID: 33128877 Free PMC article.
-
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.Front Immunol. 2020 Aug 7;11:1949. doi: 10.3389/fimmu.2020.01949. eCollection 2020. Front Immunol. 2020. PMID: 32849654 Free PMC article. Review.
-
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25. Vaccine. 2020. PMID: 32507409 Free PMC article.
Cited by
-
Comparison of HBV-specific T cell reactivity across the pregnant, postpartum and non-pregnant women with chronic HBV infection.Front Immunol. 2024 Oct 10;15:1461767. doi: 10.3389/fimmu.2024.1461767. eCollection 2024. Front Immunol. 2024. PMID: 39474421 Free PMC article.
-
Modelling the Relative Vaccine Efficacy of ARCT-154, a Self-Amplifying mRNA COVID-19 Vaccine, versus BNT162b2 Using Immunogenicity Data.Vaccines (Basel). 2024 Oct 11;12(10):1161. doi: 10.3390/vaccines12101161. Vaccines (Basel). 2024. PMID: 39460327 Free PMC article.
-
T-Cell Immune Responses to SARS-CoV-2 Infection and Vaccination.Vaccines (Basel). 2024 Sep 30;12(10):1126. doi: 10.3390/vaccines12101126. Vaccines (Basel). 2024. PMID: 39460293 Free PMC article. Review.
-
Dual Functionality of Papaya Leaf Extracts: Anti-Coronavirus Activity and Anti-Inflammation Mechanism.Foods. 2024 Oct 16;13(20):3274. doi: 10.3390/foods13203274. Foods. 2024. PMID: 39456336 Free PMC article.
-
Investigation of Long-Term CD4+ T Cell Receptor Repertoire Changes Following SARS-CoV-2 Infection in Patients with Different Severities of Disease.Diagnostics (Basel). 2024 Oct 19;14(20):2330. doi: 10.3390/diagnostics14202330. Diagnostics (Basel). 2024. PMID: 39451653 Free PMC article.
References
-
- Welsh, R. M. & Selin, L. K. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2, 417–426 (2002). - DOI
-
- Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020). - DOI
-
- Raoult, D., Zumla, A., Locatelli, F., Ippolito, G. & Kroemer, G. Coronavirus infections: epidemiological, clinical and immunological features and hypotheses. Cell Stress 4, 66–75 (2020). - DOI
-
- Lim, M. Q. et al. Cross-Reactivity and anti-viral function of dengue capsid and NS3-specific memory T cells toward Zika virus. Front. Immunol. 9, 2225 (2018). - DOI
-
- Su, L. F., Kidd, B. A., Han, A., Kotzin, J. J. & Davis, M. M. Virus-specific CD4+ memory-phenotype T cells are abundant in unexposed adults. Immunity 38, 373–383 (2013). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous